
Alfonso Javier Tafur MD MS. RPVI.
Cardiology, Vascular Medicine
Director, Vascular Medicine Northshore University Healthsystem Assistant Clinical Professor, Medicine, University of Chicago
9650 Gross Point Rd.Suite 4900Skokie, IL 60076
Fax+1 224-251-4407
Overview of Dr. Tafur
Dr. Alfonso Tafur is a Physician Scientist in Skokie, IL and is affiliated with multiple hospitals in the area, including Evanston Hospital, Glenbrook Hospital, NorthShore Skokie Hospital, and Highland Park Hospital.
He received his medical degree from Universidad de Guayaquil Faculty of Medicine, Internal Medicine and Vascular Medicine training in Mayo Clinic, and a Masters in Clinical Research from University of Oklahoma.
Dr. Tafur has been in practice 14 years. He specializes in Vascular Medicine and is experienced in thrombophilias, cancer associated thrombosis, peri procedural anticoagulation management, and sneddon syndrome.
Education & Training
Loyola university MBA, Healthcare, 2020 - 2022
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
Universidad de Guayaquil, School of Medicine.Class of 2003
Okalhoma University HealthCenterMasters Degree, Clinical and Translational Research
Certifications & Licensure
IL State Medical License 2015 - 2029
OK State Medical License 2010 - 2016
MN State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine- ABVMVascular Medicine Specialist
Clinical Trials
- Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy Start of enrollment: 2017 Jul 14
Publications & Presentations
PubMed
- Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer.Dana Taizhanova, Nurgul Serikbay, Pedro Henrique Fernandes do Carmo Las Casas, Jovana Mijucic, Bodaubay Roza
International Journal of Molecular Sciences. 2026-08-16 - Neutrophil-to-lymphocyte ratio is associated with 30-day mortality in acute pulmonary embolism across European Society of Cardiology risk categories.Umar Hashim, Lizbeth Cabrera, Romil Patel, Mohammad Salah, Yama Sadozai
Research and Practice in Thrombosis and Haemostasis. 2026-08-01 - Navigating the pause-patient experiences with perioperative anticoagulation interruption: a qualitative study.Alfonso Tafur, Sally Jensen, Albert Marquez, Steven Greenberg, Barry Wallach
Research and Practice in Thrombosis and Haemostasis. 2026-07-01
Abstracts/Posters
- Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban By Andexanet Alfa As Measured By Whole Blood Thromboelastographic AnalysisAlfonso J Tafur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Prothrombinase Induced Clotting Time Is More Sensitive then aPTT and PT and Can be Used for the Monitoring of Anti-Xa Agents in Whole Blood and PlasmaAlfonso J Tafur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Andexanet Alpha Differentially Neutralizes the Anticoagulant, Antiprotease and Thrombin Generation Inhibitory Effects of Unfractionated Heparin, Enoxaparin and Fondapa...Alfonso J Tafur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
A Closer Look at the Possible Medical Complications from the Johnson and Johnson VaccineApril 13th, 2021
Most Don't Need 'Bridging' When They Stop Warfarin TemporarilyAugust 26th, 2015
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: